These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12864890)

  • 1. Burden of end-stage renal disease among indigenous peoples in Australia and New Zealand.
    McDonald SP; Russ GR
    Kidney Int Suppl; 2003 Feb; (83):S123-7. PubMed ID: 12864890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current incidence, treatment patterns and outcome of end-stage renal disease among indigenous groups in Australia and New Zealand.
    McDonald SP; Russ GR
    Nephrology (Carlton); 2003 Feb; 8(1):42-8. PubMed ID: 15012749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increases in renal replacement therapy in Australia and New Zealand: understanding trends in diabetic nephropathy.
    Grace BS; Clayton P; McDonald SP
    Nephrology (Carlton); 2012 Jan; 17(1):76-84. PubMed ID: 21854505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry.
    McDonald SP; Russ GR; Kerr PG; Collins JF;
    Am J Kidney Dis; 2002 Dec; 40(6):1122-31. PubMed ID: 12460029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence of treated end-stage renal disease in New Zealand Maori and Pacific Island people and in Indigenous Australians.
    Stewart JH; McCredie MR; McDonald SP
    Nephrol Dial Transplant; 2004 Mar; 19(3):678-85. PubMed ID: 14767026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inequity in dialysis related practices and outcomes in Aotearoa/New Zealand: a Kaupapa Māori analysis.
    Huria T; Palmer S; Beckert L; Williman J; Pitama S
    Int J Equity Health; 2018 Feb; 17(1):27. PubMed ID: 29458366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in the dialysis treatment of Indigenous and non-Indigenous Australians.
    McKercher C; Jose MD; Grace B; Clayton PA; Walter M
    Aust N Z J Public Health; 2017 Feb; 41(1):15-20. PubMed ID: 27960225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interpreting incidence trends for treated end-stage renal disease: implications for evaluating disease control in Australia.
    Stewart JH; McCredie MR; Williams SM; McDonald SP
    Nephrology (Carlton); 2004 Aug; 9(4):238-46. PubMed ID: 15363056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dialysis outcomes of elderly Indigenous and non-Indigenous Australians.
    McKercher C; Chan HW; Clayton PA; McDonald S; Jose MD
    Nephrology (Carlton); 2014 Oct; 19(10):610-6. PubMed ID: 25066470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney disease among the indigenous peoples of Oceania.
    Weil EJ; Nelson RG
    Ethn Dis; 2006; 16(2 Suppl 2):S2-24-30. PubMed ID: 16774006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demography and survival of patients receiving treatment for chronic renal failure in Australia and New Zealand: report on dialysis and renal transplantation treatment from the Australia and New Zealand Dialysis and Transplant Registry.
    Disney AP
    Am J Kidney Dis; 1995 Jan; 25(1):165-75. PubMed ID: 7810521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival of Indigenous Australians receiving renal replacement therapy: closing the gap?
    Lawton PD; Cunningham J; Zhao Y; Gray NA; Chatfield MD; Baade PD; Murali K; Jose MD
    Med J Aust; 2015 Mar; 202(4):200-4. PubMed ID: 25716603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disparity of access to kidney transplantation by Indigenous and non-Indigenous Australians.
    Khanal N; Lawton PD; Cass A; McDonald SP
    Med J Aust; 2018 Sep; 209(6):261-266. PubMed ID: 30208818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nationwide survey of adolescents and young adults with end-stage kidney disease.
    Ritchie AG; Clayton PA; Mackie FE; Kennedy SE
    Nephrology (Carlton); 2012 Aug; 17(6):539-44. PubMed ID: 22489755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and treatment of ESRD among indigenous peoples of Australasia.
    McDonald S
    Clin Nephrol; 2010 Nov; 74 Suppl 1():S28-31. PubMed ID: 20979960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional variation in the incidence of end-stage renal disease in Indigenous Australians.
    Cass A; Cunningham J; Wang Z; Hoy W
    Med J Aust; 2001 Jul; 175(1):24-7. PubMed ID: 11476198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the pathways leading from disadvantage to end-stage renal disease for indigenous Australians.
    Cass A; Cunningham J; Snelling P; Wang Z; Hoy W
    Soc Sci Med; 2004 Feb; 58(4):767-85. PubMed ID: 14672592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbidity recording and predictive power of comorbidities in the Australia and New Zealand dialysis and transplant registry compared with administrative data: 2000-2010.
    Kotwal S; Webster AC; Cass A; Gallagher M
    Nephrology (Carlton); 2016 Nov; 21(11):930-937. PubMed ID: 26636746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of renal recovery in Australian and New Zealand end-stage renal failure patients treated with peritoneal dialysis.
    Craven AM; Hawley CM; McDonald SP; Rosman JB; Brown FG; Johnson DW
    Perit Dial Int; 2007; 27(2):184-91. PubMed ID: 17299156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.